GSK-FDC116114

Study Sponsor: GSK

Study Title

Implementation of a screening tool for subjects with benign prostatic enlargement/obstruction to identify men >=50 years presenting in General Practice with other co-morbidities who should be assessed for BPH

Medicine or Vaccine (generic name)

dutasteride/tamsulosin

Sponsor Identification Number

FDC116114

Trial Registry Identification Number(#'s)

NCT02757963

Medical Condition

Prostatic Hyperplasia

Phase

Phase 4

Link to study details on the GSK Clinical Study Register

https://www.gsk-studyregister.com/en/trial-details/?id=116114

Link to study details on ClinicalTrials.gov (if available)

http://clinicaltrials.gov/show/NCT02757963

Link to study details on EudraCT (if available)

Datasets and Documents Available for this Study

Raw dataset	Annotated case report form	Dataset specifications	Protocol with any amendments
Analysis-ready dataset	Reporting and analysis plan	Clinical study report	Ready to Share

Additional information about the data and documents available for this study

Date Added to this Site

November 2020